29,056 resources
By Version
By Authority
By Realm
Start Prev Rows 6600 - 6800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1571 | Hypotony of Eye | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1572 | Hypotony of Eye | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1574 | Injury to Optic Nerve and Pathways | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1575 | Injury to Optic Nerve and Pathways | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1577 | Central Corneal Ulcer | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1578 | Central Corneal Ulcer | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1582 | Open Wound of Eyeball | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1583 | Open Wound of Eyeball | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1587 | Pathologic Myopia | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1588 | Pathologic Myopia | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1590 | Posterior Lenticonus | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1591 | Posterior Lenticonus | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1601 | Retrolental Fibroplasias | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1603 | Retrolental Fibroplasias | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1612 | Traumatic Cataract | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1613 | Traumatic Cataract | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1615 | Uveitis | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1617 | Uveitis | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1618 | Vascular Disorders of Iris and Ciliary Body | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1620 | Vascular Disorders of Iris and Ciliary Body | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1621 | Visual Field Defects | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1623 | Visual Field Defects | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1626 | Amblyopia | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1628 | Amblyopia | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1632 | Choroidal Degenerations | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1634 | Choroidal Degenerations | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1635 | Choroidal Detachment | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1637 | Choroidal Detachment | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1638 | Choroidal Hemorrhage and Rupture | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1640 | Choroidal Hemorrhage and Rupture | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1641 | Degeneration of Macula and Posterior Pole | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1643 | Degeneration of Macula and Posterior Pole | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1644 | Degenerative Disorders of Globe | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1646 | Degenerative Disorders of Globe | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1647 | Diabetic Macular Edema | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1649 | Diabetic Macular Edema | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1653 | Disorders of Optic Chiasm | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1655 | Disorders of Optic Chiasm | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1656 | Disorders of Visual Cortex | active | 2021-04 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1658 | Disorders of Visual Cortex | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1659 | Disseminated Chorioretinitis and Disseminated Retinochoroiditis | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1661 | Disseminated Chorioretinitis and Disseminated Retinochoroiditis | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1662 | Focal Chorioretinitis and Focal Retinochoroiditis | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1664 | Focal Chorioretinitis and Focal Retinochoroiditis | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1665 | Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1667 | Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1668 | Hereditary Choroidal Dystrophies | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1670 | Hereditary Choroidal Dystrophies | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1671 | Hereditary Retinal Dystrophies | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1673 | Hereditary Retinal Dystrophies | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1677 | Nystagmus and Other Irregular Eye Movements | active | 2021-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1679 | Nystagmus and Other Irregular Eye Movements | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1680 | Optic Atrophy | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1682 | Optic Atrophy | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1683 | Optic Neuritis | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1685 | Optic Neuritis | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1686 | Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1688 | Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1689 | Other Background Retinopathy and Retinal Vascular Changes | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1691 | Other Background Retinopathy and Retinal Vascular Changes | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1695 | Other Disorders of Optic Nerve | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1697 | Other Disorders of Optic Nerve | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1701 | Other Endophthalmitis | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1703 | Other Endophthalmitis | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1707 | Prior Penetrating Keratoplasty | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1709 | Prior Penetrating Keratoplasty | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1713 | Purulent Endophthalmitis | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1715 | Purulent Endophthalmitis | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1716 | Retinal Detachment with Retinal Defect | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1718 | Retinal Detachment with Retinal Defect | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1719 | Retinal Vascular Occlusion | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1721 | Retinal Vascular Occlusion | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1722 | Other Proliferative Retinopathy | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1724 | Other Proliferative Retinopathy | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1728 | Separation of Retinal Layers | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1730 | Separation of Retinal Layers | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1731 | Visual Acuity 20/40 or Better | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.175 | Hypotension | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1752 | Speech and Hearing Evaluation | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.176 | Arrhythmia | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1766 | Morgagnian Cataract | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1767 | Morgagnian Cataract | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1769 | Macular Scar of Posterior Polar | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.177 | Atrioventricular Block | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1770 | Macular Scar of Posterior Polar | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1771 | Ophthalmological Services | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1772 | Annual Wellness Visit | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1773 | Speech and Hearing Evaluation | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1774 | Occupational Therapy Evaluation | active | 2021-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1775 | Behavioral Neuropsych Assessment | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1776 | Psych Visit Diagnostic Evaluation | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1777 | Psych Visit Psychotherapy | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1778 | Psychoanalysis | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1779 | Group Psychotherapy | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.178 | Cardiac Pacer in Situ | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1780 | Psych Visit for Family Psychotherapy | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1781 | Best Corrected Visual Acuity Exam Using Snellen Chart | active | 2021-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.180 | Hypotension | active | 2023-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.181 | Arrhythmia | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.183 | Cardiac Pacer in Situ | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.185 | Hypotension | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.186 | Arrhythmia | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.187 | Atrioventricular Block | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1912 | Major Depressive Disorder Active | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1918 | Major Depressive Disorder Active | active | 2023-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1923 | Psych Visit Diagnostic Evaluation | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1924 | Cardiac Pacer in Situ | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.408 | Bradycardia | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.410 | Bradycardia | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.411 | Bradycardia | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.422 | Tobacco User | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.423 | Tobacco Use Cessation Pharmacotherapy | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.424 | Tobacco Use Cessation Counseling | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.425 | Tobacco Use Cessation Counseling | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.450 | Pain Warranting Further Investigation for Prostate Cancer | active | 2023-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.469 | Bilateral Oophorectomy | active | 2017-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.470 | Bilateral Oophorectomy | active | 2024-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.483 | Chemotherapy | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.484 | Chemotherapy | active | 2021-08 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.511 | Tobacco Non User | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.532 | Pregnancy | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.56 | Coronary Artery Disease No MI | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.57 | Coronary Artery Disease No MI | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.58 | Initial Myocardial Infarction | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.589 | End Stage Renal Disease | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.59 | Asthma | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.590 | End Stage Renal Disease | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.60 | Asthma | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.61 | Asthma | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.73 | Primary Open Angle Glaucoma | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.74 | Primary Open Angle Glaucoma | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.76 | Diabetic Retinopathy | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.80 | Diabetic Retinopathy | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.859 | Left Ventricular Systolic Dysfunction | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.860 | Moderate or Severe | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.861 | Moderate or Severe LVSD | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.91 | Prostate Cancer | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.92 | Prostate Cancer | active | 2025-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1002 | Chronic Kidney Disease, Stage 5 | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1005 | Dementia and Mental Degenerations | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1006 | Standardized Tools Score for Assessment of Cognition | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1007 | Medical Reason | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1008 | Patient Reason | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1010 | Cancer | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1011 | Occupational Therapy Evaluation | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1012 | Patient Provider Interaction | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1018 | Psych Visit for Family Psychotherapy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1023 | Behavioral or Neuropsych Assessment | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1026 | Radiation Treatment Management | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1027 | Chemotherapy Administration | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1028 | Standardized Pain Assessment Tool | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1090 | Moderate or Severe LVSD | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1091 | Left Ventricular Systolic Dysfunction | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1092 | Moderate or Severe | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1134 | Ejection Fraction | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1139 | ACE Inhibitor or ARB or ARNI | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1140 | Patient Reason for ACE Inhibitor or ARB Decline | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1141 | Psychoanalysis | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1151 | Renal Failure Due to ACE Inhibitor | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1170 | Tobacco User | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1174 | Beta Blocker Therapy | active | 2021-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1176 | Heart Rate | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1177 | Allergy to Beta Blocker Therapy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1178 | Intolerance to Beta Blocker Therapy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1184 | Beta Blocker Therapy for LVSD | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1187 | Group Psychotherapy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1189 | Tobacco Non User | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1190 | Tobacco Use Cessation Pharmacotherapy | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1193 | Cardiac Pacer | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1211 | Allergy to ACE Inhibitor or ARB | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1212 | Intolerance to ACE Inhibitor or ARB | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1240 | Annual Wellness Visit | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1241 | Acute and Subacute Iridocyclitis | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1251 | Macular Exam | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1259 | Limited Life Expectancy | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1278 | Tobacco Use Screening | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1283 | Level of Severity of Retinopathy Findings | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1285 | Ophthalmological Services | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1320 | Macular Edema Findings Present | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1332 | Cognitive Assessment | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1333 | Cup to Disc Ratio | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1334 | Optic Disc Exam for Structural Abnormalities | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1409 | Burn Confined to Eye and Adnexa | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1410 | Cataract Secondary to Ocular Disorders | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1411 | Cataract Surgery | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1412 | Cataract Congenital | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1413 | Cataract Mature or Hypermature | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1414 | Cataract Posterior Polar | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1415 | Certain Types of Iridocyclitis | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1416 | Chronic Iridocyclitis | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1417 | Cloudy Cornea | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1418 | Corneal Edema | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1419 | Disorders of Cornea Including Corneal Opacity | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1423 | Glaucoma | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1424 | Hereditary Corneal Dystrophies | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1426 | Hypotony of Eye | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1427 | Injury to Optic Nerve and Pathways | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1428 | Central Corneal Ulcer | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1430 | Open Wound of Eyeball | active | 2021-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1432 | Pathologic Myopia | active | 2022-03 | us | hl7 | vsac |